Since 2004, the University of Minnesota's research portfolio has grown by 41% – the second-highest growth rate among U.S. public research universities. This phenomenal growth rate has helped pushed U of M to 9th among the nation’s top research universities. In fact, the University of Minnesota garnered a record $823M in outside research funding for 2010. In addition, 14 new companies were launched in past 18 months from the University-based technologies. This resulted in the University garnering nearly$84M in gross annual revenue from patent and licensing activity in 2010.
Recently, the University of Minnesota received a $51 million, five-year Clinical and Translational Science Award from the National Institutes of Health. This money will be for health research in: diabetes, cancer, cardiology, neurological disorders and infectious diseases.
Additionally, the University of Minnesota will receive nearly $17 million from Dow over the next five years to encourage research in chemical and materials sciences. Of the $17M, almost $2.3 million per year, for five years will go to researchers in: chemical engineering and materials science, chemistry, and mechanical engineering researchers in the University of Minnesota’s College of Science and Engineering. Further, in support of scientific research, Dow has made a $5 million dollar commitment to help fund building expansion in Amundson Hall, the home of the highly ranked Department of Chemical Engineering and Materials Science.
Moreover, University of Minnesota researchers are now one step closer to making renewable petroleum fuels from bacteria, sunlight and carbon dioxide, with a $2.2 million dollar grant from the U. S. Department of Energy.
Minnesota photo galleries show researchers having a great time learning about new lab research products click below to see photos of our Minnesota events:
|Rochester, MN: http://info.biotech-calendar.com/rochester-minnesota-bioresearch-product-faire/|
|University of Minnesota, Twin Cities: http://info.biotech-calendar.com/university-of-minnesota-twin-cities-bioresearch-product-faire/|
|University of Minnesota, St. Paul: http://info.biotech-calendar.com/university-of-minnesota-st-paul-front-line-event-photo-gallery/|
If interested, upcoming 2013 Minnesota events:
|09/25/2013||8th Annual||Rochester, Minnesota||Rochester||MN|
|09/26/2013||13th Annual||University of Minnesota, Twin Cities||Minneapolis||MN|
|09/27/2013||5th Annual Front Line Event**||University of Minnesota, St. Paul||St. Paul||MN|
In a year the, Mayo Clinic received $369 million in government, foundation and industry funding, which was supplemented by funds and benefactor gifts of $400 million.
The Mayo clinic has a NIH 2011 Ranking of 29th (Direct plus indirect costs but excluding R & D contracts and ARRA awards) with its funding totaling $193,905,832.
Some of the recent research grants at the Mayo clinic:
-Mayo Clinic (Rochester event) received a $48 million grant from the National Institutes of Health and industry to research treatment of atrial fibrillation in 3,000 patients in 140 centers around the world.
-Mayo Clinic was awarded $11.2 million to continue research in Pharmacogenomics (the study of how genetics effect a patient's response to medication).
-Researchers at the University of Minnesota and Mayo Clinic have received a $1.35 million grant to study a form of blood cancer called myelodysplastic syndrome.
-Mayo Clinic was awarded $9,867,850 from the National Institutes of Health, in order to develop a population genetics analysis program.
-The Minnesota Partnership for Biotechnology and Medical Genomics announced six new projects in 2010. The Partnership rewarded $5 million in state funded research support to six new investigative teams in 2010 to provide the initial support for research on cancer, neurological conditions and autoimmune diseases. The Partnership is a collaboration of the State of Minnesota, the University of Minnesota, and Mayo Clinic.
If interested in more information about Mayo Funding stats see link: